Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis

NCT02275299 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Iguratimod
DRUG: Leflunomide
DRUG: Methotrexate

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.